REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms > Additional Hetero Ring Containing > The Additional Hetero Ring Is One Of The Cyclos In A Polycyclo Ring System The Additional Hetero Ring Is One Of The Cyclos In A Polycyclo Ring SystemThe Additional Hetero Ring Is One Of The Cyclos In A Polycyclo Ring System patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/18/07 - 20070015795 - Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities The present invention concerns a composition prepared from a combination of non β-oxidizable fatty acid entities and a protein material, and the use of said composition for the preparation of a pharmaceutical or nutritional composition for the prevention and/or treatment of insulin resistance, obesity, diabetes, fatty liver, hypercholesterolemia, dyslipidemia, atherosclerosis, ... 01/11/07 - 20070010559 - Indole derivatives for use as chemical uncoupler Novel 3-vinylsulfonyl indole derivatives are chemical uncouplers useful e.g. for treatment of obesity. ... 01/11/07 - 20070010558 - Opioid receptor antagonists A compound of the formula (I) wherein the variables X1 to X5, R1 to R7 including R3′, E, q, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and ... 12/28/06 - 20060293362 - Nitro-substituted hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them The invention relates to nitro-substituted 7-hydroxyindoles, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active compounds for treating diseases which can be influenced by using the compounds according to the invention ... 11/30/06 - 20060270710 - Methods for inhibition of angiogenesis The present invention describes methods for inhibition angiogenesis in tissues using organic peptidomimetic αvβ3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing αvβ3 antagonists. The antagonists are organic compounds having a basic group and an acidic group spaced from ... 11/23/06 - 20060264471 - 3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derviatives and use thereof as medicines for treating schizophrenia wherein (a) is a single or double bond; W is CH, CH2, CHCH3, C(CH3)2, C(CH2)2 or C(CH2)3; X is N; and Y is H or F, and salts, hydrates, tautomers, pure enantiomers, and enantiomeric mixtures; and a method of treating schizophrenia comprising administering same. ... 11/16/06 - 20060258715 - Therapeutic combinations for the treatment or prevention of depression or a pharmaceutically acceptable salt thereof, wherein each of R1, R2, R3, n, y, and Ar are as defined and described herein. ... 11/16/06 - 20060258714 - Chromane and chromene derivatives and uses thereof wherein each of R1, R2, R3, R4, y, m, n, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety ... 11/16/06 - 20060258713 - Treatment of pain or a pharmaceutically acceptable salt thereof, wherein each of R1, R2, R3, n, y, and Ar is as defined and described herein. The present invention also provides pharmaceutical compositions for treating pain containing a pain treating effective amount of the compound of formula I. ... 11/16/06 - 20060258712 - Methods for modulating bladder function This invention provides methods and pharmaceutical compositions for modulating bladder function, and in particular for maintaining bladder control or treating urinary incontinence. ... 11/16/06 - 20060258711 - Treatment of drug abuse or a pharmaceutically acceptable salt thereof, wherein each of R1, R2, R3, Ar, y, and n are as defined herein. ... 11/16/06 - 20060258710 - Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists The invention relates to a group of novel indole compounds of Formula (I): wherein: R1, R2, R4, R6, R6a, R7, R8, R9, R10, and A are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods ... 11/09/06 - 20060252799 - Benzo (f) insoindol derivatives and their use as ep4 receptor ligands and pharmaceutically acceptable derivatives thereof, which bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder. ... 11/02/06 - 20060247276 - Benzofuranyl alkanamine derivatives and uses thereof wherein each of R1, R1′, R2, R3, R4, n, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of ... 10/26/06 - 20060241149 - Chemical compounds Pyridinyl-benzoheterocycyl kinase inhibitor compounds are disclosed. Also disclosed are methods of making such compounds as well as methods of using the same in the treatment of diseases. ... 10/19/06 - 20060235051 - Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases cased by the orthopoxvirus. ... 10/12/06 - 20060229339 - Novel use of substituted aminomethyl chromans Compounds of formula I in which R has a meaning as indicated in claim 1, or one of their optical isomers or pharmaceutically acceptable salts, used for the treatment of extrapyramidal movement disorders and/or adverse effects in extrapyramidal movement disorders and/or for the treatment of extrapyramidal symptoms (EPS) induced by ... 09/28/06 - 20060217422 - Exo-selective synthesis of himbacine analogs This application discloses a novel process for the synthesis of himbacine analogs, as well as the compounds produced thereby. The synthesis proceeds by alternative routes including the cyclic ketal amide route, the chiral carbamate amide route, and the chiral carbamate ester route. The compounds produced thereby are useful as thrombin ... 09/28/06 - 20060217421 - Fortifier An agent for enhancing therapeutic or prophylactic effect of administering an inhibitor of renin-angiotensin system, such as candesartan cilexetil, on renal diseases is disclosed. The agent comprises a specific prostaglandin I derivative such as beraprost sodium as an effective ingredient. ... 09/14/06 - 20060205790 - Medicinal arylethanolamine compounds and salts, solvates and physiologically acceptable derivatives thereof, to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases. ... 08/10/06 - 20060178405 - Benzopyran compounds, process for preparing the same and their use The invention relates to the benzopyran compounds of formula (I), or the salts thereof, in which, the bond between 3 and 4 positions is a single or double bond; R1 represents a hydrogen atom or a C1-6 alkyl that can be substituted; R2 represents a hydrogen atom, a C1-6 alkyl ... 07/27/06 - 20060167055 - Non-nucleoside reverse transcriptase inhibitors A compound of the formula (Y): where; R1 is O, S; R2 is a nitrogen-containing heterocycle; R3 is H, C1-C3 alkyl; X is —(C8R8)n-D-(C8C8′)m—; D is a bond, —NR9—, —O—, —S—, —S(═O)— or —S(═O)2; n and m are independently 0, 1 or 2, R8 and R8′ are independently H, C1-C3 ... 06/22/06 - 20060135564 - Insecticidal compositions comprising compounds having inhibitory activity versus acyl coa: cholesterol acyltransferase or salts thereof as effective ingredients The present invention relates to insecticidal compositions comprising compounds having an inhibitory activity versus acyl CoA:cholesterol acyltransferase (ACAT) or salts thereof as effective ingredients. The compounds having inhibitory activity versus ACAT have an excellent insecticidal effect by inhibiting sterol metabolism in noxious insects. Therefore, the compounds of the present invention ... 06/08/06 - 20060122232 - 4-hydroxyfuroic acid derivatives This invention relates to treating diabetes mellitus with certain 4-hydroxyfuroic acid derivatives. These derivates are of formula (I) below. Each variable is defined in the specification. ... 05/25/06 - 20060111401 - Taxanes having a c10 carbonate substituent Taxanes having a methylcarbonate or ethylcarbonate substituent at C(10), a hydroxy substituent at C(7), and a range of C(13) side chain substituents. ... 03/16/06 - 20060058354 - Conjugated aromatic compounds with a pyridine substituent The compounds of the present invention are NMDA (N-methyl-D-aspartate)-receptor subtype blockers and are used in the treatment of diseases related to this receptor. ... 03/16/06 - 20060058353 - Benzofuran derivatives, process for their preparation and intermediates thereof Compound of formula (I) wherein A is selected from pyridin-2-yl or thiazol-2-yl and R1, R2 and R3 are as described in the specification and their use in the treatment or prevention of a disease or medical conditions mediated through glucokinase. ... 02/23/06 - 20060040990 - Epothilone derivatives, process for their production, and their pharmaceutical use which are useful as pharmaceutical compounds for treating, for example, malignant tumors and chronic inflammatory diseases and are useful in anti-angiogenesis therapy. ... 01/19/06 - 20060014797 - Sleep inducing compounds and methods relating thereto including stereoisomers, prodrugs, and pharmaceutically acceptable salts, esters and solvates thereof, wherein R1, R2, R3a, R3b, L1, L2 and n are as defined herein. Such compounds generally function as H1 receptor ligands, and thus have utility as sleep inducing agents. Pharmaceutical compositions containing a compound of structure (I), as well ... 01/19/06 - 20060014796 - Epothilone derivatives The present invention relates to C4-demethyl-epothilones or C4-bisnor-epothilones of Formula (I), their pharmaceutical use, pharmaceutical composition containing the same and methods for their preparation. ... 12/01/05 - 20050267155 - Constrained himbacine analogs as thrombin receptor antagonists X is —O— or —NR6— when the double-dashed line represents a single bond; X is H, —OH or —NHR20 when the double-dashed line represents an absent bond; and other parameters are as defined herein. Also disclosed are pharmaceutical compositions and combinations containing said compounds and their uses as thrombin receptor ... 11/24/05 - 20050261347 - Dihydrobenzofuranyl alkanamine derivatives and methods for using same wherein each of R1a, R2a, R3a, Ar, y, and m are as defined herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, are used to treat a variety of central nervous system disorders such as schizophrenia. ... 10/13/05 - 20050228025 - Substituted oxindole derivatives as tyrosine kinase inhibitors The present invention is related to oxindole derivatives of structure (I), compositions containing the same, and methods of use and manufacture of the same. Such compounds generally are useful pharmacologically as agents in those disease states alleviated by the alteration of mitogen activated signaling pathways in general, and in particular ... 10/13/05 - 20050228024 - Pharmaceutical compositions comprising a benzofuran derivative and their use for the treatment of attention deficit/hyperactivity disorder The compound of formula (I): or a pharmaceutically acceptable salt thereof, especially the mesylate salt, is of use in a method for the treatment and/or prevention of attention-deficit/hyperactivity disorder (ADHD). ... 09/29/05 - 20050215594 - 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions. ... 09/15/05 - 20050203145 - 6-alkylamino-2,2'-disubstituted-7,8-disubstituted-2h-1-benzopyran derivatives as 5-lipoxygenase inhibitor When a multi-step process reaction is carried out in a solution, it generally requires several treatments and purification procedures to go through with after the reaction, however, the inventive method for preparing 2,2′-disubstituted-3,4-dihydro-7,8-disubstituted-6-amino benzopyran derivative using a solid-phased synthetic method simplifies the treatment and purification procedures after the reaction, which ... 09/15/05 - 20050203144 - Bicyclo[3.1.0]hexane containing oxazolidinone antibiotics and derivatives thereof its enantiomer, diastereomer, or pharmaceutically acceptable salt or ester thereof, and wherein the variables R1, R2, R3, R4, R4a, A, Ar, HAr, n, r, and s are as defined herein. ... 09/08/05 - 20050197364 - Amide compounds as ion channel ligands and uses thereof The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others. ... 08/18/05 - 20050182098 - C10 carbamoyloxy substituted taxane compositions Compositions comprising a taxane having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substituents. ... ### FreshPatents.com Support |